2018
DOI: 10.1097/ta.0000000000001893
|View full text |Cite
|
Sign up to set email alerts
|

Intravenous administration of synthetic platelets (SynthoPlate) in a mouse liver injury model of uncontrolled hemorrhage improves hemostasis

Abstract: Transfusion of SynthoPlate particles reduces blood loss in a murine model of liver injury, and SynthoPlates may represent a viable transfusion product for the mitigation of blood loss in acute, severe hemorrhagic shock.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
44
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 36 publications
(45 citation statements)
references
References 26 publications
0
44
0
Order By: Relevance
“…SynthoPlates are liposomes decorated with ligands that bind VWF, collagen, and fibrin, which allow them to recapitulate the binding properties of activated platelets. [68][69][70] This platform has decreased hemorrhage and improved survival in preclinical bleeding trauma models, [71][72][73] and has also shown the ability to deliver hemostatic drugs to bleeding sites. 72 Synthetic platelets require further preclinical testing and validation but will likely soon be ready for human testing.…”
Section: Novel Therapeutic Approaches To Platelet Dysfunctionmentioning
confidence: 99%
“…SynthoPlates are liposomes decorated with ligands that bind VWF, collagen, and fibrin, which allow them to recapitulate the binding properties of activated platelets. [68][69][70] This platform has decreased hemorrhage and improved survival in preclinical bleeding trauma models, [71][72][73] and has also shown the ability to deliver hemostatic drugs to bleeding sites. 72 Synthetic platelets require further preclinical testing and validation but will likely soon be ready for human testing.…”
Section: Novel Therapeutic Approaches To Platelet Dysfunctionmentioning
confidence: 99%
“…Collagen and von Willebrand factor-binding peptides were incorporated to mimic platelet adhesion, while a fibrinogen-mimetic peptide was incorporated to promote platelet aggregation. Such synthetic platelets called SynthoPlate were found to reduce blood loss compared to controls (unmodified liposomes and normal saline) in a mouse liver injury model with uncontrolled intraperitoneal hemorrhage [121].…”
Section: Synthetic Plateletsmentioning
confidence: 99%
“…Increasing evidence support the role of PMPs in angiogenesis and cancer progression. hemorrhagic injury in a pig model (137,138). This novel biomaterial can be sterilized and stored as lyophilized powder for long periods of time, a great advantage for their use in remote places or at war conflict locations.…”
Section: Platelets As Carriers: "Beware Of Platelets Bearing Gifts"mentioning
confidence: 99%